AVIRAGEN THERAPEUTICS
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates: laninamivir octanoate, which the Company is developing for the treatment of influenza A and B infections in the United States. through a contract with the U.S. Office of Biomedical Advanced Research and Development Authority (BARDA)... that provides up to $231 million in financial support to complete its clinical development; and vapendavir, a potent, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus. In addition to these clinical-stage development programs, the Company has preclinical programs focused on developing treatments for respiratory syncytial virus.
AVIRAGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
1984-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.aviragentherapeutics.com
Total Employee:
51+
Status:
Closed
Contact:
678-221-3343
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps IPv6 Microsoft Exchange Online Office 365 Mail Google Maps API Akamai Hosted Barracuda Networks
Similar Organizations
SelectX Pharmaceuticals Inc.
SelectX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of aminoglycoside therapeutics.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-03 | Anaconda Pharma | Anaconda Pharma acquired by Aviragen Therapeutics | N/A |
| 2012-04-23 | Nabi Biopharmaceuticals | Nabi Biopharmaceuticals acquired by Aviragen Therapeutics | N/A |
Official Site Inspections
http://www.aviragentherapeutics.com
Unable to get host informations!!!
More informations about "Aviragen Therapeutics"
Aviragen Therapeutics - PitchBook
Aviragen Therapeutics General Information Description. Developer of direct-acting antivirals designed to treat infections that have limited therapeutic options. The company is engaged in the discovery and development of an oral โฆSee details»
Organization | Aviragen Therapeutics
Organization Overview. First Clinical Trial. 2007 NCT00311714. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Aviragen Therapeutics, Inc. | Biota Holdings Ltd | โฆSee details»
Biota Pharmaceuticals, Inc. Announces Name Change to
Contacts: Mark Colonnese Executive Vice President and Chief Financial Officer Aviragen Therapeutics, Inc. (678) 221-3381 [email protected] Beth DelGiacco โฆSee details»
BIOTA - Company Profile & Staff Directory - ContactOut
Aviragen Therapeutics is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a โฆSee details»
Aviragen Therapeutics Information - RocketReach
Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have โฆSee details»
Aviragen Therapeutics - LinkedIn
Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have โฆSee details»
Aviragen Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Aviragen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 38 clinical trials, 14 news, and 33 literature, Disease Domain:Infectious Diseases, Technology โฆSee details»
Aviragen Therapeutics
Oct 23, 2024 Aviragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of direct-acting antivirals to treat infections that affect a โฆSee details»
Aviragen Therapeutics - Craft
Aug 4, 2022 Aviragen Therapeutics, formerly Biota Pharmaceuticals, is a biopharmaceutical company. The Company is focused on the discovery and development of direct-acting โฆSee details»
Aviragen Therapeutics | VentureRadar
Aviragen Therapeutics® is focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a โฆSee details»
Aviragen Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Aviragen Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Infectious Diseases, Technology Platform ...See details»
Company Aviragen Therapeutics Inc Nasdaq - MarketScreener.com
Oct 24, 2019 Business description: Aviragen Therapeutics Inc Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant โฆSee details»
Aviragen Therapeutics - LinkedIn
Aviragen Therapeutics | 1,551 followers on LinkedIn. Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of โฆSee details»
Biota Pharmaceuticals, Inc. Announces Name Change to Aviragen ...
On April 12, 2016 Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) reported that the Company has changed its name to Aviragen Therapeutics, Inc., ("Aviragen Therapeutics"), a pharmaceutical โฆSee details»
Aviragen Therapeutics - Products, Competitors, Financials, โฆ
Aviragen Therapeutics is a biopharmaceutical company that focuses on the discovery and development of next-generation antivirals. Use the CB Insights Platform to explore Aviragen โฆSee details»
Aviragen Therapeutics - Funding, Financials, Valuation & Investors
Organization. Aviragen Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Funding. Aviragen Therapeutics is โฆSee details»
Aviragen Therapeutics, Vaxart Enter into Merger Agreement
Oct 30, 2017 Aviragen Therapeutics and Vaxart announced the companies have entered into a definitive merger agreement. The merger will result in a combined company, Vaxart, focused โฆSee details»
Aviragen Therapeutics, Inc. (Aviragen Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
May 2, 2023 ไบ่งฃAviragen Therapeutics, Inc. (Aviragen Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็37้กนไธดๅบ่ฏ้ช, 14็ฏๆฐ้ปๅ61็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:ๆๆ๏ผๆๆฏๅนณ โฆSee details»